The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases.
Shamriz O, Hershko AY, Talmon A, Ribak Y, Elazary AS, Horev L, NaserEddin A, Neuman T, Shabat S, Zlotogorski A, Tal Y.
Shamriz O, et al. Among authors: shabat s.
Allergol Int. 2021 Apr;70(2):266-268. doi: 10.1016/j.alit.2020.10.001. Epub 2020 Oct 21.
Allergol Int. 2021.
PMID: 33779559
Free article.
No abstract available.